Huating Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Huating Li has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Bin Sheng
Shanghai Jiao Tong University
2 shared publications Ling Dai
Shanghai Jiao Tong University
2 shared publicationsQiang Wu
Shanghai Jiao Tong University, Sixth People’s Hospital
2 shared publicationsRuogu Fang
University of Florida
2 shared publicationsWeiping Jia
Shanghai Jiao Tong University, Sixth People’s Hospital
2 shared publicationsXuhong Hou
Shanghai Jiao Tong University, Sixth People’s Hospital
2 shared publications
Latest Publications
- Open Access
- 15 February 2019
- Published by Springer Nature
- p. C1-C2
Correction to: Retinal Microaneurysm Detection Using Clinical Report Guided Multi-Sieving CNN
- 15 February 2019
- Published by Springer Nature
- p. C1-C2
Open AccessCorrection to: Retinal Microaneurysm Detection Using Clinical Report Guided Multi-Sieving CNN
- 4 September 2017
- Published by Springer Nature
- p. 525-532
Retinal Microaneurysm Detection Using Clinical Report Guided Multi-sieving CNN
- 4 September 2017
- Published by Springer Nature
- p. 525-532
Retinal Microaneurysm Detection Using Clinical Report Guided Multi-sieving CNN
- 1 November 2008
- Vol. 14 (11) , CR552-8
Glycemic variability and its responses to intensive insulin treatment in newly diagnosed type 2 diabetes.
Recent data show that blood glucose (BG) variability is an HbA1c-independent risk factor for diabetic complications. This study investigated the characteristics of BG variability in type 2 diabetic patients and the effect of intensive treatment. Forty-eight subjects with normal glucose regulation and 69 patients with newly diagnosed type 2 diabetes were monitored using the continuous glucose monitoring system. A subset of the type 2 diabetic patients (n=23) whose HbA1c was >8.5% was monitored a second time following 2 to 3 weeks of treatment with multiple daily injections. The mean amplitude of glycemic excursions (MAGE), mean of daily differences (MODD), and the incremental areas above preprandial glucose values (AUCpp) were used for assessing intra-day, inter-day, and postprandial BG variability. In type 2 diabetic patients, the MAGE, MODD, and AUCpp levels were all higher than those of subjects with normal glucose regulation (P<0.001). Multivariant regression analysis indicated that AUCpp was the main independent factor influencing MAGE (Adjusted R2=0.56), while postprandial hyperglycemia was most prominent following breakfast and less evident during lunch and dinner. After intensive treatment, significant decreases in MAGE, MODD, and AUCpp were observed (41%, 29%, and 49%, respectively, P<0.001). AUCpp after breakfast was higher than after lunch and dinner (P<0.05). In 65.2% of the subjects, peak intra-day values occurred 103+/-30 minutes after breakfast. Minimizing glycemic variability in type 2 diabetic patients, especially postprandial glucose excursions following breakfast, may be an important aspect of glucose management.
- 1 November 2008
- Vol. 14 (11) , CR552-8
Glycemic variability and its responses to intensive insulin treatment in newly diagnosed type 2 diabetes.
Recent data show that blood glucose (BG) variability is an HbA1c-independent risk factor for diabetic complications. This study investigated the characteristics of BG variability in type 2 diabetic patients and the effect of intensive treatment. Forty-eight subjects with normal glucose regulation and 69 patients with newly diagnosed type 2 diabetes were monitored using the continuous glucose monitoring system. A subset of the type 2 diabetic patients (n=23) whose HbA1c was >8.5% was monitored a second time following 2 to 3 weeks of treatment with multiple daily injections. The mean amplitude of glycemic excursions (MAGE), mean of daily differences (MODD), and the incremental areas above preprandial glucose values (AUCpp) were used for assessing intra-day, inter-day, and postprandial BG variability. In type 2 diabetic patients, the MAGE, MODD, and AUCpp levels were all higher than those of subjects with normal glucose regulation (P<0.001). Multivariant regression analysis indicated that AUCpp was the main independent factor influencing MAGE (Adjusted R2=0.56), while postprandial hyperglycemia was most prominent following breakfast and less evident during lunch and dinner. After intensive treatment, significant decreases in MAGE, MODD, and AUCpp were observed (41%, 29%, and 49%, respectively, P<0.001). AUCpp after breakfast was higher than after lunch and dinner (P<0.05). In 65.2% of the subjects, peak intra-day values occurred 103+/-30 minutes after breakfast. Minimizing glycemic variability in type 2 diabetic patients, especially postprandial glucose excursions following breakfast, may be an important aspect of glucose management.